Cancer experts write to the government to demand life-extending drug to be used on the NHS
Kidney cancer specialists from around the UK have written to [...]
Immunicum submits application to FDA for INTUVAX
Immunicum, a Swedish biopharmaceutical company developing therapeutic cancer immunotherapies, has submitted [...]
Cabozantinib and lenvatinib recommended for approval by the EMA
Cabozantinib (Cabometyx, Ipsen Pharma) and lenvatinib (Kisplyx, Eisai Europe Ltd) [...]
Sutent (sunitinib) improves disease-free survival in kidney cancer patients at high risk of recurrence following surgery
Pfizer announced this week that the phase III S-TRAC clinical [...]
Nivolumab blocked by NICE for kidney cancer
Disappointing news for kidney cancer patients: the National Institute for [...]
